The <i>Listeria</i> Small RNA Rli27 Regulates a Cell Wall Protein inside Eukaryotic Cells by Targeting a Long 5′-UTR Variant by Juan J. Quereda (651911)

“…The 234-nucleotide 5′-UTR is also the target of a small RNA (sRNA) denoted Rli27, which we identified by bioinformatics analysis as having extensive base pairing potential with the long 5′-UTR. …”

Decreased infiltration of Th1 cells and CD11b⁺ myeloid cells into spinal cord in ES-DC-treated mice. by Tokunori Ikeda (425940)

Research dataset of the study. by Faranak Mahmoudi Alami (18309967)

“…Axial magnetic resonance images from the L2 to S1 lumbar levels were used to evaluate the morphology of the lumbar muscles.</p><p>Results</p><p>A significant increase in the muscle-to-fat infiltration index and a significant decrease in the relative muscle cross-sectional area (rmCSA) of the multifidus muscle at the L3-L4 to L5-S1 levels were observed in both CNLBP groups compared to the control group (p<0.05). …”

Study sample characteristics by groups. by Faranak Mahmoudi Alami (18309967)

“…Axial magnetic resonance images from the L2 to S1 lumbar levels were used to evaluate the morphology of the lumbar muscles.</p><p>Results</p><p>A significant increase in the muscle-to-fat infiltration index and a significant decrease in the relative muscle cross-sectional area (rmCSA) of the multifidus muscle at the L3-L4 to L5-S1 levels were observed in both CNLBP groups compared to the control group (p<0.05). …”

Increased apoptosis and decreased cell proliferation in <i>BAF155/170</i>^{<i>Wnt1-CKO</i>} embryos. by Kathleen Wung Bi-Lin (10344956)

<i>sirB⁻</i>, Vic1, Vic2 and T6SS-double mutants showed decreased virulence in planta. by Johanna Nykyri (124297)

Lysozyme activity in different experimental groups in tilapia. by Sinthia Kabir Mumu (17705902)

Plasma cortisol concentration in different experimental groups in tilapia. by Sinthia Kabir Mumu (17705902)

Blood glucose concentrations of tilapia in different experimental groups (control, stress, prevention, and treatment) were examined. by Sinthia Kabir Mumu (17705902)

<i>Nrf2</i> expression in <i>Hesr1</i>/<i>Hesr3</i>-double null primary myoblasts is decreased. by Masahiko Yamaguchi (801411)

The residual signaling activity of γ2-MSH and γ3-MSH in plasma is MCR specific and plasma stability decreased compared to CNS stability. by Karin Löw (8805416)

Dilated endoplasmic reticulum and altered Golgi distribution in patient cells suggest an intracellular trafficking defect. by Ronit Marom (4454017)

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Metformin is effective against ERα^- and ERα⁺ breast cancer cells, and decreases ERα levels. by Gerald Davies (4666435)